Study on the Health Economic Burden of Alzheimer's Disease in China
ConditionAlzheimer Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-100
SponsorXuanwu Hospital, Beijing
About this trial
Alzheimer's disease (AD) presents a significant socio-economic challenge globally, with China experiencing a notable rise in its prevalence. This study addresses critical gaps in understanding AD's economic burden and quality of life (QoL) impacts on patients and caregivers in Mainland China.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
History of stroke with neurological focal signs and imaging findings consistent with cerebral small vessel disease (Modified Fazekas score ≥2).
Presence of mental or neurological developmental delay.
Presence of other known conditions that may cause cognitive impairment.
Diagnosis of a disease that prevents completion of cognitive assessments.
Trial population
The study covered all 31 provincial administrative units in mainland China, divided into six regions (Central and South/ Northeast/ East/ Central and South/ Southwest and Northwest)
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
There was no intervention as this was an observational study.
Other interventionThere was no intervention as this was an observational study.
Treatment groups
9,510 Participants
are divided into 4 treatment groupsGroup A: amnestic mild cognitive impairment(aMCI）1 intervention
Group B: mild AD1 intervention
Group C: severe AD1 intervention
Group D: Moderate AD1 intervention
Trial outcomes
Primary outcomes
1
Direct medical expenses
Direct medical expenses refer to the expenses incurred by patients and/or their families for medical and health services related to Alzheimer's disease
Time frame
baseline2
Direct non-medical expenses
The direct non-medical costs of Alzheimer's disease include care costs, home facilities and repair costs, health care products costs and related expenses incurred during medical treatment. The cost of care includes the salary of caregivers, the expenses of external caregivers, and the travel expenses of caregivers
Time frame
baseline3
overhead expenses
Indirect costs include the economic loss caused by patients' inability to work, the decrease in the income of informal caregivers, the treatment expenses of caregivers' psychological diseases and the medical expenses incurred by patients with Alzheimer's disease or caregivers due to accidental injuries.
Time frame
baselineSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov